Related Experiment Video
Updated: Aug 9, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear
Kook Heon Seo1, Hyun-Mi Ko, Han-A Kim
1Department of Biological Sciences, The Institute of Basic Sciences, Chonnam National University, Kwangju, Republic of Korea.
Abstract:
In this study, we investigated the influence of platelet-activating factor (PAF) on the induction of apoptosis-regulating factors in B16F10 melanoma cells. PAF increased the expression of mRNA and the protein synthesis of antiapoptotic factors, such as Bcl-2 and Bcl-xL, but did not increase the expression of the proapoptotic factor, Bax. A selective nuclear factor-kappaB (NF-kappaB) inhibitor, parthenolide, inhibited the effects of PAF. Furthermore, PAF inhibited etoposide-induced increases in caspase-3, caspase-8, and caspase-9 activities, as well as cell death. p50/p65 heterodimer increased the mRNA expression of Bcl-2 and Bcl-xL and decreased etoposide-induced caspase activities and cell death. In an in vivo model in which Matrigel was injected s.c., PAF augmented the growth of B16F10 cells and attenuated etoposide-induced inhibition of B16F10 cells growth. These data indicate that PAF induces up-regulation of antiapoptotic factors in a NF-kappaB-dependent manner in a melanoma cell line, therefore suggesting that PAF may diminish the cytotoxic effect of chemotherapeutic agents.
Insights
Platelet-activating factor (PAF) promotes melanoma cell survival by increasing antiapoptotic factors via nuclear factor-kappaB (NF-kappaB). This suggests PAF may reduce chemotherapy effectiveness in B16F10 melanoma.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Melanoma cell proliferation and apoptosis are critical factors in cancer progression.
- Platelet-activating factor (PAF) is implicated in various cellular processes, including inflammation and cell survival.
- Understanding molecular mechanisms regulating melanoma cell fate is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the role of platelet-activating factor (PAF) in modulating apoptosis-regulating factors in B16F10 melanoma cells.
- To elucidate the involvement of nuclear factor-kappaB (NF-kappaB) signaling in PAF-mediated effects on melanoma cells.
- To assess the impact of PAF on the efficacy of chemotherapeutic agents in melanoma models.
Main Methods:
- Quantitative real-time PCR to measure mRNA expression of apoptosis-regulating factors.
- Western blotting to assess protein synthesis of antiapoptotic and proapoptotic factors.
- Inhibition studies using a selective nuclear factor-kappaB (NF-kappaB) inhibitor, parthenolide.
- Enzyme activity assays for caspases (caspase-3, -8, -9).
- In vivo studies using a Matrigel-based subcutaneous model with B16F10 melanoma cells.
Main Results:
- PAF significantly increased mRNA and protein expression of antiapoptotic factors Bcl-2 and Bcl-xL in B16F10 cells.
- PAF did not increase the expression of the proapoptotic factor Bax.
- Inhibition of NF-kappaB by parthenolide blocked PAF-induced changes in antiapoptotic factors.
- PAF attenuated etoposide-induced increases in caspase activities and melanoma cell death.
- PAF promoted B16F10 cell growth in vivo and reduced the inhibitory effect of etoposide.
Conclusions:
- Platelet-activating factor (PAF) induces the up-regulation of antiapoptotic factors, specifically Bcl-2 and Bcl-xL, in a melanoma cell line.
- This effect is dependent on nuclear factor-kappaB (NF-kappaB) signaling.
- PAF may reduce the cytotoxic efficacy of chemotherapeutic agents like etoposide by promoting melanoma cell survival.
More Related Videos
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply